DA Davidson Maintains Buy on Lion Electric, Lowers Price Target to $4
DA Davidson analyst Michael Shlisky maintains Lion Electric (NYSE:LEV) with a Buy and lowers the price target from $5 to $4.
Credit Suisse Downgrades Diversey Hldgs to Neutral, Lowers Price Target to $8.4
Credit Suisse analyst John Roberts downgrades Diversey Hldgs (NASDAQ:DSEY) from Outperform to Neutral and lowers the price target from $9 to $8.4.
Citigroup Downgrades Petco Health and Wellness to Neutral, Announces $11 Price Target
Citigroup analyst Steven Zaccone downgrades Petco Health and Wellness (NASDAQ:WOOF) from Buy to Neutral and announces $11 price target.
Alembic Global Upgrades Methanex to Overweight, Announces $60 Price Target
Alembic Global analyst Hassan Ahmed upgrades Methanex (NASDAQ:MEOH) from Neutral to Overweight and announces $60 price target.
DA Davidson Upgrades Joint to Neutral, Raises Price Target to $15
DA Davidson analyst Linda Bolton Weiser upgrades Joint (NASDAQ:JYNT) from Underperform to Neutral and raises the price target from $12 to $15.
Truist Securities Maintains Buy on FTI Consulting, Raises Price Target to $240
Truist Securities analyst Tobey Sommer maintains FTI Consulting (NYSE:FCN) with a Buy and raises the price target from $220 to $240.
Morgan Stanley Maintains Overweight on Nike, Raises Price Target to $140
Morgan Stanley analyst Alexandra Steiger maintains Nike (NYSE:NKE) with a Overweight and raises the price target from $138 to $140.
Morgan Stanley Maintains Equal-Weight on Ulta Beauty, Raises Price Target to $535
Morgan Stanley analyst Simeon Gutman maintains Ulta Beauty (NASDAQ:ULTA) with a Equal-Weight and raises the price target from $510 to $535.
Oppenheimer Maintains Outperform on Coinbase Glb, Lowers Price Target to $70
Oppenheimer analyst Owen Lau maintains Coinbase Glb (NASDAQ:COIN) with a Outperform and lowers the price target from $84 to $70.
Raymond James Maintains Outperform on Aris Water Solutions, Lowers Price Target to $15
Raymond James analyst Justin Jenkins maintains Aris Water Solutions (NYSE:ARIS) with a Outperform and lowers the price target from $20 to $15.